Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being

Por Anand, Ernie, Berggren, Lovisa, Landry, John, Tóth, Ágoston, Detke, Holland C
Publicado no Neuropsychiatr Dis Treat (2016)

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendat...

Por Anand, Ernie, Berggren, Lovisa, Deix, Claudia, Tóth, Ágoston, McDonnell, David P
Publicado no Neuropsychiatr Dis Treat (2015)